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Abstract
Obesity prevalence has been growing exponentially over the last few decades, with a high impact in high-income
countries, like Qatar. Several approaches are attempting to understand the causes of this phenomenon however
more important is what to do to reverse the trends. Obesity is widely studied, mostly in Europe and the Unites
States, and a number of studies have demonstrate the role of specific gene patterns, transcriptome and proteome
pathways, and gut microbiome strains. The Omics sciences have a great potential to investigate the determinants of
non-communicable diseases, such as obesity. Nutritional genomics sciences apply all the Omics approaches to
address nutrition-related diseases, investigating the interaction between genes and diet. To date, few data are
available from nutrigenomic studies conducted in Middle East and particularly in Qatar to help the design of targeted
interventions. The high incidence of obesity and the peculiar genetic make-up of the Qatari population provide
opportunities for exploring nutrigenomic approaches to help addressing the problem.
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Introduction
Obesity, diabetes, cardiovascular diseases, and other non-
communicable diseases (NCDs) account for more than 60 per cent of
annually global deaths [1], and this is estimated to increase
exponentially by 2025. The World Health Organization (WHO) defines
as overweight a body mass index (BMI) ≥ 25 kg/m2, and as obesity a
BMI ≥ 30 kg/m2 [2,3]. The global prevalence of the overweight and
obesity is on the rise, as demonstrated by the first Global Burden of
Metabolic Risk Factors of Chronic Diseases in 2008 [3], and confirmed
by the Global Burden of Disease Study 2013. The first study analyzed
data from 199 countries and territories and 9.1 million adults with
respect to the prevalence of overweight and obesity between 1980 and
2008 [3], and demonstrated that the prevalence of obesity nearly
doubled worldwide during that 28-year period (about 34% overweight
and 12% obesity). More recently, the analyses for the Global Burden of
Disease Study 2013 [4] further documented that worldwide, the
proportion of adults with a BMI of 25 kg/m2 or greater increased
between 1980 and 2013 from about 29% to 37% in men and from
about 30 to 38% in women. Since 2006, the increase in adult obesity
seems to have leveled off in several high-income countries, but the
incidence generally remains higher than in most low- and middle-
income countries [5] (Figure 1A).
Obesity in Qatar
The Middle East has a peculiar demographic pattern and
environmental characteristics reflective of an obesogenic environment.
The Middle East also has the highest prevalence of obesity in relatively
high-income economies (Figure 1B). BMI is considered the most
relevant risk factor for NCDs and high BMI frequency is duplicated in
the decades 1990 to 2010 in the high-income Arab countries,
explaining the increase in NCDs as causes of death [6,7]. In the Qatari
context, between 2004 and 2010, the top four NCDs causes of death in
Qatar were: circulatory disorders; cancers; endocrine, nutritional and
metabolic disorders; and respiratory diseases. The distributions of
deaths from these major causes in 2012 were as follows: circulatory,
18.3% total (20%, Qatari population); neoplasms, 16.1% total, (21.6%,
Qataris); endocrine and metabolic, 9.9% total, (14.1%, Qataris);
respiratory, 5.5% total, (7.5%, Qataris) [8]. Diabetes accounts for a very
high proportion of the 14.1 per cent mortality from endocrine,
nutritional and metabolic disorders. NCDs are the main cause of death
in Qatar [9]. Health statistics reveal that, in 2010, the total deaths in
Qatar among the different age-groups due to NCDs was approximately
50 percent [10].
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Established but modifiable risk factors for obesity, cardiovascular
disease and diabetes include physical inactivity, excessive energy intake
and consumption of animal fats, including trans fatty acids. During the
past four decades, Qatar has gone through a revolution in its socio-
economic status, which has led to changes in their food habits,
consumption patterns, lifestyles, and health status [9,11-13]. The
healthy traditional food habits, characterized mainly by the
consumption of vegetables, fruits, milk and beans, shifted to a western-
like food habits characterized by higher intake of meat, trans fats, and
carbohydrates, coupled with lower intake of vegetables and fruit, which
are the main risk factors for obesity [14-16]. The sedentary lifestyle
together with an obesity-promoting diet has led to the marked increase
in levels of overweight and obesity among Qatari [13]. This change in
dietary pattern and lifestyle among Qatari population is associated
with increased prevalence of diet-related chronic diseases such as
cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM),
hypertension, obesity, cancer, and osteoporosis [17-21].
Figure 1: Prevalence of overweight worldwide (Figure 1A) and Middle East (Figure 1B) from 2014 WHO country profile (Reprinted from
“Prevalence of overweight, age 18+, 2010-2014 (age standardized estimate). Both sex. 2014”, http://gamapserver.who.int/gho/
interactive_charts/ncd/risk_factors/overweight/atlas.html, Copyright WHO 2015).
The data about obesity are alarming, with more than 70% of the
adult population overweight or obese [4]. The young population is
extremely affected, as well. A cross sectional study of 1213 Qatari
children (683 girls and 530 boys) aged 9-11 years old showed that the
prevalence of overweight and obesity affected 21.1% and 17.7%,
respectively [22]. In another study, Bener and Kamal [23] reported that
the overall prevalence of overweight and obesity among children and
adolescents was 19.8% and 4.3%, respectively [23]. The prevalence of
overweight and obesity increased with age with a maximum rate was
observed among boys compared to girls. The same pattern was
observed among adolescents. Results of a study conducted among a
representative sample of 1167 secondary school children (526 boys and
641 girls) aged 14-20 years old, showed that 21.4% of adolescents were
overweight and 20.7% were obese [24].
Genetic determinants of obesity: the peculiar case of Qatar
A paper published in Nature Genetics in the 2009 identified 17 new
loci associated with BMI [25] resulted from a genome wide association
study (GWAS). These loci were linked to appetite control, neuronal
control, growth and development, intracellular lipid transport,
adipocyte metabolism, and cellular apoptosis. The Database Online
Mendelian Inheritance in Man (OMIM) identifies more than 500 gene
variants associated to the obesity [26]. Although GWAS studies
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identified a rich source of candidate genes, which permit a
personalized nutritional approach to obesity, they not yet defined the
genetic pathway that underlies obesity onset in the general population
[27,28]. Additionally, it has to be noted that most of these studies have
mainly been focused on Western populations and their findings do not
necessarily apply to populations of a different genetic background. A
recent study interestingly showed that the genetic risk for T2DM
decreased as humans migrated toward East Asia, highlighting a genetic
risk differentiation across human populations [29].
In Qatar and other Middle East countries, local studies are lacking.
Clearly, additional research is warranted to clarify possible specific
genetic determinants in population disproportionately affected by
obesity and NCDs, like the Qatari and Middle Eastern populations.
The Qatari population is characterized by a very small size and a
peculiar genetic background that defines three genetic groups
according to their migration history (Bedouin, Persian-South Asian,
and African tribes) [30]. Moreover the practice of first-cousin
marriages has resulted in high level of inbreeding, with a consanguinity
rate that can reach 54% [31]; noteworthy, more than 70% of the adult
population is overweight or obese [4]. A recent study from Mezzavilla
and colleagues [32] has pointed carbohydrate metabolism as one of the
functional pathways identified by homozygosity mapping in the Qatari
population. Additionally, two studies started to explore possible
candidate genes for obesity in Qatari subjects: the first identified an
association of PPARγ variant with obesity and hypertension [33]. The
second one has tested the relevance of 23 loci found associated to
obesity in previous studies in the Qatari population. The SNPs were
chosen as mapping within or nearby well-documented obesity genes
(including FTO and MC4R) and as representative of the obesity status
(both in terms of BMI and waist circumference) [34]. Interestingly,
only two of the 23 SNPs were found to be associated to obesity in the
Qatari population, suggesting the existence of additional loci whose
number and effect size still remain unknown. A more intense effort
should be put in the identification of obesity loci specific for the Qatari
population.
Although genetic factors can determine the propensity of an
individual to develop obesity, the recent increase in obesity probably
reflects environmental and lifestyle changes where dietary change is a
major contributor and could interact with the genetic background [35].
Nutrigenomic approaches to obesity
Nutritional genomics refers to sciences that study the interactions
between dietary components and the genome as well as resulting
changes in gene expression, proteins and metabolite activities.
Transcriptome, methylome, metabolome, and microbiome
composition are the arguments pointed by nutrigenomics and
metabolomics. Recently, advanced technologies (as next generation
sequencing, high-density micro-arrays, mass spectrometry, and
bioinformatics) allowed us to easily approach these sciences [36]. Great
interest is growing around the opportunities from the personalized
nutrition and its application to the complex diseases, as obesity. Several
studies reported significant results in nutrigenomics, but we are far
from the complete list of food-gene interactions [37,38]. Some
successful examples are in cancers: for example, Lee and colleagues
demonstrated that β-carotene consumption is protective against breast
cancer in subjects with the diplotype TG: TG at codons 786-894 of
NOS3 gene, on the contrary vitamin E is protective in TC or TT
individuals for NOS3 codon 786, and in GT or TT for NOS3 codon
894 [39]. Fatty fish consumption was inversely associated with risk of
prostate cancer in Swedish men carrying the variant rs5275 at gene
COX2 [40]. Naturally, also obesity studies identified potentially genetic
targets interacting with specific nutrients [41], for example a study
from Mattei et al. [42] demonstrated that dietary fat intake interacts
with TCF7L2 rs7903146, changing BMI, total fat mass and trunk fat
mass [42]; another study from Zhang et al. [43] found that high-
protein diet interacts with FTO rs15558902, improving weight loss,
body composition and body fat distribution [43]. Other examples
come from literature particularly from Europe and America, while the
situation is different in Middle East, where the nutrigenomic approach
to obesity and NCDs is still starting first attempts. Fahed et al. [15] 3
years ago, asked a call for nutritional genomics research in Arabic
countries from North Africa to the Middle East [15]. In the meantime,
only few studies were completed: the first study measured the
metabolic perturbations in T2DM patients in Qatar; another one
evaluated the DNA methylation in T2DM Palestinian patients; the last
evaluated the smoking effect on DNA methylation in Qatari subjects
[44-46].
Under the definitions of epigenetics we can insert the classical DNA
methylation and histone acetylation mechanisms, as well as miRNA
transcriptional control. It’s well established that epigenetic mechanisms
are involved in obesity, creating the “cycle of obesity” among the
generations [47]. Both maternal and paternal diet influences obesity
susceptibility in the offspring [48]. On the other hand, maintaining the
appropriate metabolite level depends on gene regulation operated by
specific miRNAs in target tissues, like adipose tissue, pancreas, liver,
etc. [49]. The only Qatari study on epigenetics investigated possible
epigenetic effects of smoking. The authors confirmed other population
data, finding higher smoking impact in women, particularly in two
proteins AHRR and PAR4, involved in cell growth and differentiation
and platelet activation, respectively [45]. Another study in Arab
population is from Toper off and colleagues, who identified an inverse
correlation between leukocyte methylation status and T2DM,
independent of sex and BMI, but increased by age [46].
Recent whole-genome transcriptome studies demonstrated different
gene pathways activation in obese subjects. Lee et al. [50] investigated
a time-course change in gene expression in mice during 24 weeks high
fat diet, and identified differential expressed gene in oxidative
phosphorylation, lipid metabolism and cell cycle pathways. The
authors also investigated the differences in brown adipose tissue (BAT)
genes respect to white adipose tissue (WAT), reporting increased levels
of leptin and adiponectin in BAT and a consequent differential
immune response [50]. A similar study measured the gene expression
changes in mice WAT and liver tissues after long-term high fat diet,
and confirmed a transcriptome transition in the 24 analyzed weeks,
that evolved in the perturbation of lipid metabolism and immune
system homeostasis [51]. The only human study is conducted on 1200
multiethnic subjects, and more the 10.000 gene levels were measured
in purified monocytes. The authors demonstrated that the most
significant pathway associated to BMI was cholesterol metabolism.
Moreover they discovered that this pathway correlated with the
inflammatory markers IL-6 and CRP, and with increased risk to
develop type 2 diabetes and coronary arterial calcifications [52]. No
Qatari or Arabic transcriptome studies on obesity were identified in
recent publications.
Microbiome and metabolomics
Gut microbiota is a dynamic structure, which evolves from the birth
to adulthood, and several factors such as diet, genetic background, and
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immune status affect its composition. Alterations in one or more of
this mechanism may be the cause of microbiome shift in several
chronic inflammation diseases, like inflammatory bowel diseases,
obesity, diabetes, asthma, non-alcoholic fatty liver disease (NAFLD)
[53,54]. Advances in technologies, like next generation sequencing
(NGS), allowed evaluating the whole microbiota composition in
different conditions. The composition of the microbiota can modulate,
through different mechanisms, the efficiency of energy extraction from
the diet [55], lipid metabolism and storage in the liver and adipose
tissue, intestinal permeability, modulating secretion of
enteroendocrine hormones, affecting bile acid metabolism and
inducing metabolic endotoxemia and inflammation [56-58].
It is now recognized that the development of obesity is associated
with alterations in the gut microbial composition and activity. Obese
individuals have an altered gut microbiota compared to lean controls
[56]. Analysis of the gut microbiome and metabolic functions in obese
and lean mice revealed an enrichment of genes involved in energy
harvest, including genes involved in sensing and degrading dietary
mono- and polysaccharides [59,60], in small chain fatty acids (SCFAs)
metabolism [61], and amino acid metabolism, generating bioactive
metabolites, as histamine and γ-amino butyric acid (GABA), which
have immune-regulatory and anti-inflammatory functions [57]. Both
intestinal and systemic inflammation, associated to different
microbiota pattern, was observed in obese subjects vs not obese
subjects, due to dendritic cell activation [62], and to the increased
intestinal permeability. Several immune cell receptors, like Toll-like
receptors (TLRs), have been shown to be activated by
lipopolysaccharides (LPS), bacterial DNA, and peptidoglycan derived
from the gut microbiota, leading to cytokine production and inhibition
of insulin signaling through NF-kB or MAPK pathways [63]. The gut
microbiota thus directly contributes to obesity by increasing energy
harvest and nutrient metabolism from the diet, and activating
inflammatory response.
Altered dietary intake has a major impact on gut microbial
composition [64], and this can promote obesity and increase the risk of
developing NCDs. Both its cellular composition and gene transcription
network are rapidly altered in response to dietary shifts [56,65,66].
Dietary modification and probiotics / prebiotics supplementation are
suggested as possible therapeutic approach to obesity, diabetes and
other metabolic diseases, which involve microbiome changes [67-69].
Single countries or population studies well demonstrated that
microbiome is influenced by environment and genetics, and changes
across among populations [64,70,71], and the current knowledge about
microbiome comes mostly from European and American studies. No
data are available about microbiome composition in Qatari
population, and moreover no study correlated microbiome with
obesity in this population. We expect to find peculiar microbiome
pattern in this population that could explain the higher incidence of
obesity and CVDs [12].
Few studies were published on microbiome and human diseases in
Middle East. A paper from Qatar University described possible
microbiome investigation with germ-free animal models, and one
study was already published on male fertility and microbiome role
using this model [72,73]. The only human study is from Alokail and
colleagues, which described the protocol to investigate probiotic effects
in Saudi T2DM patients. The study is in progress and hopefully, it will
provide evidences of benefic effects in diabetic patients, modulating
microbiota and reducing inflammatory response [74].
Microbial activity is evaluated also measuring bacterial and human
produced metabolites. Diet can modulate metabolite phenotype, and
targeted analyses are performed to evaluate the effect of specific diets
on metabolic disorders [75]. Several metabolomics studies have
already been performed in the field of obesity and T2DM [76,77].
Metabolites from lipids, amino acids, and carbohydrates pathways are
associated with BMI [78]. Mostly intercellular lipid intermediates,
sphingolipids and bile acid intermediates are associated to obesity [77].
Microbial metabolism produces SCFAs from host amino acids, and
changes in plasma levels of some amino acids are associated with
T2DM [79], particularly aromatic amino acids. In a Qatari study,
predictors of T2DM were identified in different body fluids, saliva,
plasma, and urine, at different timescales of glycemic control, revealing
a connection between metabolites across the body fluids and a specific
association of metabolites with the timescales of glycemic control [44].
Future perspectives in Qatar
The nutrigenomic tools show a great potentiality for Qatar
development and to improve health care system. The current studies
about obesity in Qatar are mainly focused on epidemiology
[6,20,21,80,81], genetics [33,34], cellular studies [82], and
metabolomics [44]. No data are available about nutrigenomics,
epigenetics, and transcriptome and microbiome analysis.
Qatar is making great efforts to develop research and education in
the country [83,84]. Qatar government proposed a development plan,
the Qatar National Vision 2030, based on four pillars: economic, social,
human and environmental development [85]. The human development
pillar is focused on build an educated and healthy population, and a
capable and motivated workforce. Qatar Foundation (QF), a national
non-profit organization for education, science and community
development, considers research as essential to national and regional
growth. Obesity, diabetes and cardiovascular diseases are among the
key challenges asked by QF and the Qatar National Research Fund
(QNRF) to be addressed by research community [86]. A great effort of
Qatar research institutions are working to develop the translational
research and to achieve the QNRF challenges, as Sidra Medical and
Research Center, Weill Cornell Medical College in Qatar, Qatar
Biomedical Research Institute, under the umbrella of QF, and other
national institutes as Hamad Medical Corporation, Primary Health
Care Corporation, and Qatar University. The newest technologies and
expertise in genomics, bioinformatics and statistics are available inside
the most of these institutions, which will potentially support any type
of nutrigenomic study. These assumptions will promise the high-level
outcomes from translational research and particularly from
nutrigenomics in Qatar.
Conclusions
Qatar asks to address the determinants and the therapeutic
approaches to chronic diseases, among which obesity shows a great
urgency because of the high prevalence in the country. The
nutrigenomics science will permit to assign a personalized nutritional
intervention for NCDs. Great research efforts are focused to reach high
levels of health care in Qatar.
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